Continuous monitoring of pO2 and pCO2 by microdialysis indicates physiologic status of the critically ill patients

被引:8
作者
Cajlakovic, M. [1 ,2 ]
Bizzarri, A. [1 ]
Suppan, M. [1 ]
Konrad, C. [1 ]
Ribitsch, V. [1 ,2 ]
机构
[1] Inst Chem Proc Dev & Control, Graz, Austria
[2] Graz Univ, Inst Chem, Graz, Austria
来源
SENSORS AND ACTUATORS B-CHEMICAL | 2009年 / 139卷 / 01期
关键词
Optochemical sensors; pO(2); pCO(2); Adipose tissue; Microdialysis; Phase modulation fluorometry; SUBCUTANEOUS ADIPOSE-TISSUE; OXYGEN SENSOR; PERFUSION; GLUCOSE; PH;
D O I
10.1016/j.snb.2008.11.021
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
The monitoring of dissolved oxygen and carbon dioxide in blood or organic tissues is extremely useful for respiratory studies and can be valuable in determining the physiologic status of the Critically ill patients. The measurement quantity for both O-2 and CO2 sensors is the luminescence lifetime by phase modulation fluorometry. The properties and accuracy of both types of sensors have been firstly characterised in vitro using physiological Solutions to demonstrate the fulfilment of the defined requirements for clinical applications. The presented sensors enable the measurement of pO(2) in the range 0-300 mm Hg and of pCO(2) in the range 0-150 mm Hg, respectively, with a resolution better than 1 mm Hg and accuracy better than 1 mm Hg. To verified the operating function of developed sensors in in vivo and to analyse the changes of interstitial pO(2) and pCO(2) in adipose tissue as indicators of critical ill conditions, several in vivo tests on animal and healthy volunteer have been successfully carried Out using a microdialysis catheter CMA 60 for the extraction of interstitial fluid (ISF) from the subcutaneous adipose tissue. Critical conditions similar to intensive care patients have been provoked using two different models: an animal model of haemorrhagic shock and subministration of adrenaline, which causes a local vasoconstriction in the case of experiment with human subjects. respectively. Our results proved that changes in the interstitial pCO2 and pO(2) are informative metabolic parameters for critical condition of the patients. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:181 / 186
页数:6
相关论文
共 24 条
  • [1] Astrup P., 1986, The history of blood gases, acids, and bases: Munksgaard
  • [2] BALDINI F, 2002, HDB OPTICAL FIBRE SE, P705
  • [3] New developments of an optochemical measurement system for the continuous monitoring in subcutaneous tissue by microdialysis
    Bizzarri, A.
    Konrad, C.
    Cajlakovic, M.
    Ribitsch, V.
    [J]. 2007 IEEE SENSORS, VOLS 1-3, 2007, : 1400 - 1403
  • [4] Continuous oxygen monitoring in subcutaneous adipose tissue using microdialysis
    Bizzarri, Alessandro
    Koehler, Hans
    Cajlakovic, Merima
    Pasic, Alen
    Schaupp, Lukas
    Klimant, Ingo
    Ribitsch, Volker
    [J]. ANALYTICA CHIMICA ACTA, 2006, 573 : 48 - 56
  • [5] Luminescence lifetime-based carbon dioxide optical sensor for clinical applications
    Cajlakovic, Merima
    Bizzarri, Alessandro
    Ribitsch, Volker
    [J]. ANALYTICA CHIMICA ACTA, 2006, 573 : 57 - 64
  • [6] CHEMICAL SENSORS FOR BEDSIDE MONITORING OF CRITICALLY ILL PATIENTS
    COLLISON, ME
    MEYERHOFF, ME
    [J]. ANALYTICAL CHEMISTRY, 1990, 62 (07) : A425 - &
  • [7] Optical pH, oxygen and carbon dioxide monitoring using a microdialysis approach
    Cooney, CG
    Towe, BC
    Eyster, CR
    [J]. SENSORS AND ACTUATORS B-CHEMICAL, 2000, 69 (1-2) : 183 - 188
  • [8] Measurement of glucose and metabolites in subcutaneous adipose tissue during hyperglycemia with microdialysis at various perfusion flow rates
    Ekberg, NR
    Wisniewski, N
    Brismar, K
    Ungerstedt, U
    [J]. CLINICA CHIMICA ACTA, 2005, 359 (1-2) : 53 - 64
  • [9] IMPORTANCE OF CORRECT HANDLING OF SAMPLES FOR THE RESULTS OF BLOOD-GAS ANALYSIS
    HARSTEN, A
    BERG, B
    INEROT, S
    MUTH, L
    [J]. ACTA ANAESTHESIOLOGICA SCANDINAVICA, 1988, 32 (05) : 365 - 368
  • [10] On-line arterial blood gas analysis with optodes: Current status
    Mahutte, CK
    [J]. CLINICAL BIOCHEMISTRY, 1998, 31 (03) : 119 - 130